X-79171636-T-C
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_032553.3(GPR174):āc.629T>Cā(p.Leu210Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000911 in 1,098,080 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 4 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_032553.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR174 | NM_032553.3 | c.629T>C | p.Leu210Ser | missense_variant | 3/3 | ENST00000645147.2 | NP_115942.1 | |
GPR174 | XM_047442579.1 | c.629T>C | p.Leu210Ser | missense_variant | 3/3 | XP_047298535.1 | ||
GPR174 | XM_047442580.1 | c.629T>C | p.Leu210Ser | missense_variant | 2/2 | XP_047298536.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR174 | ENST00000645147.2 | c.629T>C | p.Leu210Ser | missense_variant | 3/3 | NM_032553.3 | ENSP00000494310.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD3 exomes AF: 0.0000165 AC: 3AN: 182089Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67095
GnomAD4 exome AF: 0.00000911 AC: 10AN: 1098080Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 4AN XY: 363476
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2021 | The c.629T>C (p.L210S) alteration is located in exon 1 (coding exon 1) of the GPR174 gene. This alteration results from a T to C substitution at nucleotide position 629, causing the leucine (L) at amino acid position 210 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at